Home> Products> steris healthcare pvt ltd medicines

{ "products": [ { "_id": "66618fbe7de2b5203089d07a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "https://www.sterispharma.com/medicines/praziquna-plus/757", "description": "PRAZIQUNA PLUS \nPraziquantel Tablets USP (600mg)\nPRAZIQUNA PLUS is a medication that contains Praziquantel Tablets USP, each tablet having a dosage of 600mg. Praziquantel is an anthelmintic medication used to treat infections caused by certain types of parasitic worms such as tapeworms and flukes.\n\nKey Features:\n\nActive Ingredient: Each tablet contains 600mg of Praziquantel, the main therapeutic component.\nAnthelmintic: Praziquantel is effective against various parasitic worms, including tapeworms and flukes.\nDosage: The recommended dosage for PRAZIQUNA PLUS is determined by a healthcare professional based on the specific infection being treated and the patient's weight.\nAdministration: The tablets are usually taken orally with water. They can be taken with or without food, as directed by the healthcare provider.\nTreatment Duration: The duration of treatment varies depending on the type and severity of the infection. It is essential to complete the prescribed course of medication even if symptoms improve earlier.\nPrecautions: Patients with a history of hypersensitivity to Praziquantel or related compounds should avoid this medication. Pregnant or breastfeeding women should consult their doctor before using PRAZIQUNA PLUS.\nSide Effects: Common side effects may include nausea, vomiting, abdominal discomfort, dizziness, headache, and fatigue. These usually subside as the body adjusts to the medication.\nStorage: Store PRAZIQUNA PLUS at room temperature away from moisture and heat. Keep it out of reach of children and pets.\nConsultation: It is crucial to consult a healthcare professional before starting or stopping any medication, including PRAZIQUNA PLUS, to ensure safe and effective use.\nPRAZIQUNA PLUS is an essential medication in the treatment of parasitic worm infections, providing relief and promoting recovery when used correctly under medical supervision.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\n\n\n", "price": 126.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "body", "Call", "heat", "pets", "safe", "reach", "600mg", "water", "types", "ORDER", "Email", "weight", "doctor", "flukes", "dosage", "relief", "nausea", "Storage", "history", "fatigue", "patient", "severity", "symptoms", "headache", "vomiting", "moisture", "children", "recovery", "WhatsApp", "Pregnant", "dizziness", "tapeworms", "information", "Precautions", "Consultation", "sterispharma", "sterisonline", "Key Features", "effective use", "Administration", "PRAZIQUNA PLUS", "hypersensitivity", "room temperature", "Active Ingredient", "prescribed course", "related compounds", "specific infection", "Treatment Duration", "breastfeeding women", "healthcare provider", "Common side effects", "medical supervision", "abdominal discomfort", "essential medication", "healthcare professional", "anthelmintic medication", "various parasitic worms", "Praziquantel Tablets USP", "parasitic worm infections", "main therapeutic component" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1450, "imageuri": "https://productimages.withfloats.com/actual/66618fc153245b8b6b4ab39e.png", "tileimageuri": "https://productimages.withfloats.com/tile/66618fc153245b8b6b4ab39e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:30:22.459Z", "updatedon": "2026-03-14T06:07:56.289Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/https-www-sterispharma-com-medicines-praziquna-plus-757/1450", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PRAZIQUNA PLUS ", "category": "GENERAL RANGE", "tags": [ "PRAZIQUNA PLUS", "Praziquantel Tablets USP (600mg)", "Praziquantel 600 mg for humans", "Praziquantel 600 mg dosage", "Praziquantel 600 mg Tablet price", "Praziquantel 600 mg tablet uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a5df8cd5046d247bd5a48c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Arpiprazole Mouth Dissolving Tablets 15 mg", "description": "ARPIPRAZ 15 is a mouth-dissolving tablet containing Aripiprazole 15 mg, prescribed for schizophrenia, bipolar disorder, autism-related irritability, Tourette's disorder, and as an add-on to antidepressants for major depressive disorder. Unlike many antipsychotics that fully block dopamine, Aripiprazole acts as a partial dopamine agonist, fine-tuning rather than shutting down dopamine activity — which can mean fewer movement-related side effects for some patients. The tablet dissolves on the tongue without water, helping patients who struggle with swallowing. It's not considered habit-forming but must be taken exactly as prescribed and never stopped abruptly. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nARPIPRAZ 15 Price – Aripiprazole MD Tablet | Steris (Recommended)\nARPIPRAZ 15 – Aripiprazole Mouth Dissolving Tablet\nARPIPRAZ 15 Price – Schizophrenia & Bipolar Care\nAripiprazole 15mg MD Tablet – ARPIPRAZ Price\nARPIPRAZ 15 – Antipsychotic for Multiple Conditions\n\nRationale: Option 1 leads with the “Price” anchor required for this Schedule H drug, keeps the brand searchable alongside the generic name, and fits within the 50–60 character band.\n\nMeta Description (140–160 characters)\n\nARPIPRAZ 15 (Aripiprazole 15mg MD) treats schizophrenia, bipolar disorder & more. Check price online. Prescription only – consult your doctor first.\n\nFull CMS Article\nARPIPRAZ 15: Aripiprazole Mouth Dissolving Tablet for Schizophrenia, Bipolar Disorder, and Related Conditions\nTL;DR / AI Mode Summary\n\nARPIPRAZ 15 supplies Aripiprazole 15 mg in a mouth-dissolving format, used across a broader range of conditions than many antipsychotics — schizophrenia, bipolar disorder, autism-related irritability, Tourette's disorder, and as an adjunct to antidepressant therapy in major depressive disorder. Its defining feature is a partial dopamine agonist mechanism: rather than fully blocking dopamine like older antipsychotics, it modulates it, which is associated with a comparatively lower risk of certain movement side effects. The dissolving tablet skips the need for water, supporting patients who find conventional tablets hard to swallow.\n\nWhat Sets ARPIPRAZ 15 Apart?\n\nMost antipsychotic medicines work by blocking dopamine receptors outright. Aripiprazole takes a different approach — it acts as a partial agonist, meaning it can either boost or dampen dopamine activity depending on what the brain's current chemical state calls for. This “smart stabilizer” action is one reason Aripiprazole is prescribed across such a wide span of psychiatric conditions, from psychotic disorders to mood conditions to certain neurodevelopmental and tic-related presentations.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tARPIPRAZ 15\nActive Ingredient\tAripiprazole\nStrength\t15 mg\nForm\tMouth Dissolving Tablet (MD)\nDrug Class\tAtypical Antipsychotic — Partial Dopamine Agonist\nSchedule Status\tSchedule H – Prescription Only\nConditions ARPIPRAZ 15 Is Prescribed For\n\nSchizophrenia — helps ease hallucinations, delusions, disorganized thought, social withdrawal, and reduced motivation, supporting better day-to-day and social functioning.\n\nBipolar I Disorder — used for acute manic and mixed episodes, as well as maintenance therapy aimed at reducing relapse.\n\nMajor Depressive Disorder (adjunct) — added alongside antidepressants when depression hasn't responded fully to antidepressant treatment alone.\n\nIrritability Linked to Autism Spectrum Disorder — may reduce aggression, irritability, outbursts, and self-injurious behavior in eligible patients.\n\nTourette's Disorder — can reduce the frequency and intensity of motor and vocal tics for some patients.\n\nMechanism of Action\n\nAripiprazole works on three key receptor systems:\n\nDopamine D2 receptors — partially activated rather than fully blocked, helping normalize rather than suppress dopamine signaling\nSerotonin 5-HT1A receptors — contributing to mood stabilization and reduced anxiety\nSerotonin 5-HT2A receptors — supporting the reduction of psychotic symptoms\n\nTogether, this receptor profile helps ease hallucinations and delusions, stabilize mood swings, reduce anxiety, and support clearer cognitive functioning — while the partial-agonist approach is associated with a comparatively lower likelihood of certain movement-related side effects compared to older-generation antipsychotics.\n\nDirections for Use\nTake ARPIPRAZ 15 strictly as your doctor prescribes.\nPlace the tablet on the tongue and let it dissolve fully — no water is typically needed.\nDon't chew or crush it unless your doctor specifically advises otherwise.\nTake it at a consistent time each day.\nContinue the full course even once you start feeling better, unless your doctor says otherwise.\nNever discontinue suddenly on your own — stopping abruptly can bring symptoms back.\nPossible Side Effects\n\nCommonly reported:\n\nHeadache\nDizziness\nNausea or vomiting\nConstipation\nDry mouth\nRestlessness\nAnxiety\nInsomnia\nFatigue\nIncreased appetite\nWeight changes\n\nSerious — seek immediate medical attention for:\n\nSevere allergic reactions\nHigh fever combined with muscle stiffness\nSeizures\nDifficulty swallowing\nUncontrolled body movements\nFainting\nIrregular heartbeat\nSuicidal thoughts or sudden behavioral changes\n\nPlaceholder: incidence rates and comparative trial data pending qualified clinical reviewer sign-off before publication.\n\nTalk to your doctor promptly if any side effect feels severe or doesn't improve.\n\nWho Should Be Cautious\n\nLet your doctor know before starting if you have any of the following:\n\nDiabetes\nHeart disease, or high or low blood pressure\nLiver or kidney impairment\nSeizure disorders\nParkinson's disease\nDementia\nA history of stroke\nA history of substance use\n\nLong-term treatment often includes periodic checks of blood sugar, body weight, and general health.\n\nPregnancy & Breastfeeding\n\nAripiprazole should be used in pregnancy or while breastfeeding only if a doctor determines the benefits outweigh the potential risks. This decision should always be made in consultation with your healthcare provider.\n\nDrug Interactions to Flag for Your Doctor\n\nARPIPRAZ 15 can interact with:\n\nAntidepressants and anti-anxiety medicines\nAntiepileptic drugs\nBlood pressure medications\nCertain antifungal medicines and antibiotics\nHIV medications\nSleeping pills\nAlcohol\n\nShare a complete list of everything you're taking — prescription drugs, over-the-counter products, vitamins, and herbal supplements — with your prescriber before starting treatment.\n\nPrecautions & Storage\nTake only as prescribed; don't adjust the dose independently.\nAvoid alcohol during treatment.\nStore below 25°C, in the original packaging, away from moisture and direct sunlight.\nKeep out of reach of children.\nDon't use beyond the printed expiry date.\nHow ARPIPRAZ 15 Compares to Other Antipsychotics\nFeature\tOlder-Generation Antipsychotics\tARPIPRAZ 15 (Aripiprazole)\nDopamine Action\tFull receptor blockade\tPartial agonist — modulates rather than blocks\nMovement-Related Side Effect Risk\tComparatively higher\tComparatively lower for many patients\nRange of Approved Uses\tTypically narrower\tBroader — includes autism-related irritability and Tourette's\nAdministration\tUsually standard tablets\tAvailable in swallow-free MD format\n\nNote: The right antipsychotic and formulation is a clinical decision made by a psychiatrist based on individual patient factors.\n\nWhy Choose ARPIPRAZ 15?\n\nBeyond its versatility across several psychiatric and neurodevelopmental conditions, ARPIPRAZ 15's mouth-dissolving format removes a real practical hurdle for patients who struggle with regular tablets. It isn't considered habit-forming, and its partial-agonist mechanism offers a distinct option for psychiatrists balancing symptom control against side-effect tolerability. Manufactured to consistent quality standards, it's built for dependable day-to-day use under medical supervision.\n\nConclusion\n\nWhether the goal is easing psychotic symptoms, stabilizing mood in bipolar disorder, supporting antidepressant therapy, or reducing irritability and tics in specific conditions, ARPIPRAZ 15 offers a versatile treatment option built on Aripiprazole's distinctive dopamine-modulating action. Its dissolving tablet format simplifies daily dosing, and with consistent use under a psychiatrist's care, it supports steadier symptom management over time. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is ARPIPRAZ 15 used for? It treats schizophrenia, bipolar disorder, autism-related irritability, and Tourette's disorder, and is used as an add-on treatment for major depressive disorder.\nCan it be taken without water? Yes, it's a mouth-dissolving tablet designed to break down on the tongue without needing water.\nIs ARPIPRAZ 15 habit-forming? No, Aripiprazole isn't considered habit-forming, though it should always be used under medical supervision.\nCan I stop taking it once I feel better? No — stopping without medical guidance can cause symptoms to return; any discontinuation should be doctor-directed.\nDoes it cause weight gain? Some patients notice weight changes during treatment; a balanced diet and regular activity can help manage this.\nHow is ARPIPRAZ 15 different from other antipsychotics? It works as a partial dopamine agonist rather than fully blocking dopamine, which is linked to a lower risk of certain movement-related side effects for many patients.\nCan this medicine be used for depression? Yes, it's sometimes added alongside antidepressants when depression hasn't responded fully to antidepressant treatment alone.\nIs it suitable for autism-related irritability? It's prescribed for irritability associated with autism spectrum disorder in eligible patients, under a specialist's guidance.\nDoes ARPIPRAZ 15 interact with alcohol? Yes, alcohol should generally be avoided during treatment, as it may affect the medicine's tolerability.\nWhat serious symptoms require urgent medical attention? Severe allergic reactions, high fever with muscle stiffness, seizures, uncontrolled movements, fainting, irregular heartbeat, or sudden behavioral changes need immediate care.\nWhat health conditions should I mention to my doctor beforehand? Diabetes, heart disease, blood pressure issues, liver or kidney impairment, seizure disorders, Parkinson's disease, dementia, stroke history, and substance use history should all be disclosed.\nCan ARPIPRAZ 15 be used in pregnancy? Only if your doctor determines the benefits outweigh potential risks — this should always be discussed directly with your healthcare provider.\nDoes this medicine interact with other drugs I'm taking? It can interact with several medicine classes, including antidepressants, antiepileptics, blood pressure drugs, and certain antibiotics or antifungals — share your full medication list with your doctor.\nIs a prescription required to purchase ARPIPRAZ 15? Yes, it's a Schedule H medicine dispensed only against a valid doctor's prescription.\nHow long does it take to see results? Response time varies by condition and individual; your psychiatrist will track progress through follow-up visits.\n\n[Steris Healthcare Footer] Manufactured and marketed by Steris Healthcare Pvt. Ltd. — a WHO-GMP and ISO-certified pharmaceutical manufacturer. For queries, reach us at contact@sterispharma.com or +91 8824175417. This content is for informational purposes only and does not replace professional medical advice. Prescription only – consult your doctor.", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2480, "imageuri": "https://productimages.withfloats.com/actual/6a5df8cfa4709fd448b5e572.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5df8cfa4709fd448b5e572.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T10:30:37.014Z", "updatedon": "2026-07-20T10:30:37.014Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//arpiprazole-mouth-dissolving-tablets-15-mg/2480", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ARPIPRAZ 15", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66640af48e599e12c0eaceed", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinitapride 1mg", "description": "CT PRIDE 1 \nCinitapride (1mg)\nCT Pride 1 is a medication containing Cinitapride (1mg), which is a gastroprokinetic agent used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), functional dyspepsia, and delayed gastric emptying. Cinitapride works by stimulating the motility of the gastrointestinal tract, helping to improve the movement of food through the digestive system.\n\nHere are key points about CT Pride 1:\n\nIndications: It is prescribed for conditions like GERD (acid reflux), dyspepsia (indigestion), and other motility disorders of the stomach and intestines.\nMechanism of Action: Cinitapride acts by enhancing the release of acetylcholine, a neurotransmitter that stimulates gastrointestinal motility, leading to improved digestion and reduced symptoms.\nDosage: The usual dose is 1mg once or twice daily, as directed by a healthcare professional.\nSide Effects: Common side effects may include diarrhea, abdominal pain, nausea, and headache. Serious side effects are rare but may include allergic reactions or abnormal heart rhythms.\nPrecautions: CT Pride 1 should be used with caution in patients with certain medical conditions such as kidney or liver impairment, and it may interact with other medications, so it's important to inform the doctor about all medicines being taken.\nConsultation: Patients should consult their healthcare provider before starting or changing any medication regimen to ensure safety and effectiveness.\nCT Pride 1 with Cinitapride (1mg) is a medication that helps improve gastrointestinal motility, making it a valuable treatment option for various digestive disorders. It should be used under medical supervision and as part of a comprehensive treatment plan for gastrointestinal health. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/ct-pride-1-134165\n\n\n\n\n\n\n", "price": 112.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "1mg", "Call", "GERD", "part", "food", "Email", "Dosage", "kidney", "doctor", "nausea", "safety", "release", "reduced", "stomach", "improved", "symptoms", "WhatsApp", "CT PRIDE", "movement", "headache", "patients", "diarrhea", "medicines", "Mechanism", "usual dose", "key points", "intestines", "Precautions", "acid reflux", "indigestion", "information", "Indications", "Consultation", "sterispharma", "sterisonline", "effectiveness", "acetylcholine", "abdominal pain", "gastric emptying", "digestive system", "neurotransmitter", "Cinitapride acts", "liver impairment", "other medications", "medication regimen", "medical conditions", "allergic reactions", "healthcare provider", "Common side effects", "medical supervision", "Serious side effects", "functional dyspepsia", "abnormal heart rhythms", "gastroprokinetic agent", "gastrointestinal tract", "healthcare professional", "gastrointestinal health", "other motility disorders", "gastrointestinal motility", "valuable treatment option", "gastrointestinal disorders", "various digestive disorders", "comprehensive treatment plan", "gastroesophageal reflux disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1549, "imageuri": "https://productimages.withfloats.com/actual/66640af7fd5c3064809d8e52.png", "tileimageuri": "https://productimages.withfloats.com/tile/66640af7fd5c3064809d8e52.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T07:40:36.811Z", "updatedon": "2026-03-14T11:31:03.455Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinitapride-1mg/1549", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CT PRIDE 1 ", "category": "GASTROLOGYRANGE", "tags": [ "cinitapride 1mg side effects", "cinitapride tablet uses", "", "cinitapride 1 mg dosage", "CT PRIDE 1", "Cinitapride (1mg)", "cinitapride 1mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665da07fccd5ce1a1075551d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HYDROZOLIN ISDN ", "description": "HYDROZOLIN ISDN \nIsosorbide Dinitrate (20mg), Hydralazine (37.5mg)\nHYDROZOLIN ISDN is a combination medication containing Isosorbide Dinitrate (20mg) and Hydralazine (37.5mg), used for the treatment of certain heart conditions.\n\nComponents:\n\nIsosorbide Dinitrate (ISDN): A vasodilator that relaxes and widens blood vessels, improving blood flow and reducing the workload on the heart.\nHydralazine: Another vasodilator that works by relaxing blood vessels, leading to decreased blood pressure and improved blood flow.\nUses:\n\nManagement of heart failure, a condition where the heart is unable to pump blood effectively.\nTreatment of hypertension (high blood pressure) in certain individuals.\nDosage:\nThe recommended dose of HYDROZOLIN ISDN may vary depending on the individual's condition and response to treatment. It's important to follow the dosage instructions provided by a healthcare professional.\n\nSide Effects:\nCommon side effects of HYDROZOLIN ISDN may include headache, dizziness, flushing, rapid heartbeat, and nausea. Serious side effects such as allergic reactions or low blood pressure may occur in some individuals. Consult a healthcare provider for a complete list of side effects.\n\nPrecautions:\n\nInform your healthcare provider about any medical conditions, medications, or supplements you are taking before starting HYDROZOLIN ISDN.\nMonitor blood pressure regularly while taking this medication.\nAvoid sudden discontinuation of HYDROZOLIN ISDN without medical supervision.\nConclusion:\nHYDROZOLIN ISDN, combining Isosorbide Dinitrate and Hydralazine, is used for the management of heart failure and hypertension. It should be used as directed by a healthcare professional, with regular monitoring for side effects and therapeutic response.\nSteris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company's mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it's advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma Order Now Sterispharma's extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/hydrozolin-isdn-133305\n\n", "price": 139.0, "discountamount": 42.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GMP", "Call", "Uses", "Email", "group", "India", "Asthma", "nausea", "safety", "Urology", "company", "mission", "workload", "Oncology", "February", "flushing", "headache", "Diabetes", "WhatsApp", "customers", "medicines", "dizziness", "Nephrology", "Cardiology", "Components", "wide array", "commitment", "Pediatrics", "Management", "Conclusion", "blood flow", "Gynecology", "Dermatology", "information", "Hydralazine", "vasodilator", "supplements", "Dental Care", "medications", "Antibiotics", "Orthopedics", "Precautions", "convenience", "Navi Mumbai", "individuals", "hypertension", "two websites", "sterisonline", "diverse needs", "heart failure", "broad demands", "home delivery", "complete list", "Endocrinology", "blood vessels", "certifications", "WHO guidelines", "HYDROZOLIN ISDN", "rare conditions", "online pharmacy", "rapid heartbeat", "hydrozolin-isdn", "Gastroenterology", "General Medicine", "heart conditions", "Nasal Conditions", "recommended dose", "medical community", "affordable prices", "medical conditions", "low blood pressure", "Respiratory Issues", "high-quality drugs", "regular monitoring", "allergic reactions", "Common side effects", "high blood pressure", "healthcare provider", "healthcare products", "healthcare industry", "advanced treatments", "medical supervision", "dosage instructions", "sterispharma Order", "Isosorbide Dinitrate", "expert professionals", "Serious side effects", "therapeutic response", "various health areas", "sudden discontinuation", "combination medication", "pharmaceutical industry", "healthcare professional", "extensive product lineup", "Steris Healthcare Pvt Ltd", "essential health necessities" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1232, "imageuri": "https://productimages.withfloats.com/actual/665da0a0947ffd864eba7c72.png", "tileimageuri": "https://productimages.withfloats.com/tile/665da0a0947ffd864eba7c72.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T10:52:47.172Z", "updatedon": "2026-03-13T11:10:38.894Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//hydrozolin-isdn-/1232", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Isosorbide Dinitrate (20mg), Hydralazine (37.5mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6ae5ddc42400c0ad258fb750", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolic Acid Delayed-Release Tablets USP 360 mg", "description": "MYCOFORTIC S 360 is a pharmaceutical formulation containing Mycophenolic Acid Delayed-Release Tablets USP 360 mg. Mycophenolic Acid belongs to a class of medicines known as immunosuppressants. It is used to help prevent organ rejection in patients who have undergone kidney transplantation, as part of a combination immunosuppressive treatment regimen prescribed by a qualified healthcare professional.\n\nOrgan transplantation is an important medical procedure that helps patients with end-stage organ disease improve their quality of life. However, the body's immune system may recognize a transplanted organ as foreign and attempt to attack it. This immune response can lead to organ rejection.\n\nMYCOFORTIC S 360 contains Mycophenolic Acid, an active pharmaceutical ingredient that helps suppress certain immune responses. It works by inhibiting the proliferation of lymphocytes, which are important cells involved in the body's immune response.\n\nWith its delayed-release tablet formulation, MYCOFORTIC S 360 is designed to deliver Mycophenolic Acid through a specialized release mechanism. It is intended for use under strict medical supervision as part of an individualized post-transplant treatment plan.", "price": 816.0, "discountamount": 245.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2510, "imageuri": "https://productimages.withfloats.com/actual/6ae5ddc7bc27d43423ad0aec.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae5ddc7bc27d43423ad0aec.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-31T12:23:32.198Z", "updatedon": "2026-10-31T12:23:32.198Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolic-acid-delayed-release-tablets-usp-360-mg/2510", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOFORTIC S 360", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ae5d88f695d7aeb49179417", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Triamcinolone Acetonide Injection 40 mg IP", "description": "TRISULPHON CORT is a pharmaceutical formulation containing Triamcinolone Acetonide Injection 40 mg IP, belonging to the corticosteroid class of medicines. Triamcinolone Acetonide is a synthetic corticosteroid widely recognized for its anti-inflammatory and immunosuppressive properties. It is used under appropriate medical supervision to help manage various inflammatory, allergic, and immune-related conditions, depending on the prescribed route of administration and approved product indications.\n\nCorticosteroids play an important role in modern medical treatment because of their ability to regulate inflammatory responses within the body. By reducing the release and activity of certain substances responsible for inflammation, Triamcinolone Acetonide helps healthcare professionals manage conditions associated with swelling, redness, irritation, and inflammatory discomfort.\n\nTRISULPHON CORT Injection is intended for use under the guidance of qualified healthcare professionals. Its administration, dosage, and treatment duration should always be determined by a registered medical practitioner according to the patient's medical condition and individual requirements.", "price": 165.0, "discountamount": 45.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2508, "imageuri": "https://productimages.withfloats.com/actual/6ae5d892fe30914231ab3937.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae5d892fe30914231ab3937.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-31T12:01:19.584Z", "updatedon": "2026-10-31T12:01:19.584Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//triamcinolone-acetonide-injection-40-mg-ip/2508", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRISULPHON CORT", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ae2fef4545d3197abde920c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Faropenem Disperible Tablets 100 mg", "description": "Faropinom 100 DT is a prescription-only antibiotic that provides 100 mg of Faropenem in a dispersible tablet. Faropenem is a penem-type beta-lactam, and doctors use it to treat bacterial infections only when the causative organism is likely to respond to it.\n\nAbout Faropinom 100 DT\n\nThe active ingredient, Faropenem, stops bacteria from building a proper cell wall. The weakened bacteria cannot survive, which helps the body clear a susceptible infection.\n\nThe tablet is meant to be mixed into water before it is taken. This can suit patients who find whole tablets hard to swallow. It should be used strictly as prescribed and according to the leaflet in the pack.\n\nProduct Snapshot\nFeature\tDetails\nBrand\tFaropinom 100 DT\nActive ingredient\tFaropenem 100 mg\nClass\tPenem beta-lactam antibiotic\nForm\tDispersible tablet\nMode of action\tBlocks bacterial cell-wall synthesis\nAvailability\tPrescription-only; subject to Indian regulations\nPurpose\tTreating susceptible bacterial infections on a doctor’s advice\nWhere Faropenem May Be Used\n\nWhether Faropenem is chosen depends on the patient’s condition, the bacteria involved (suspected or confirmed), prevailing treatment guidelines and the approved product information. Infections for which it may be considered include:\n\nRespiratory infections: bacterial infections of the airways or lungs, where the organism is sensitive to Faropenem.\nUrinary infections: bacterial infections of the bladder or wider urinary tract, at a clinician’s discretion.\nEar, nose and throat infections: certain bacterial infections of the ears, throat or sinuses, after examination.\nSkin and soft-tissue infections: selected bacterial skin infections, depending on severity and the organisms responsible.\nOther infections: any further use must follow approved indications, laboratory susceptibility and the treating doctor’s judgement.\n\nPlease note: This antibiotic does not suit every infection. It should never be assumed appropriate for all chest, urinary, skin or genital conditions. Only a qualified healthcare professional can decide whether it is right for a particular patient.\n\nNotable Characteristics\n\n1. Bactericidal action. Faropenem attacks susceptible bacteria by interfering with the machinery that builds their cell walls. How well it works depends on the species and its susceptibility.\n\n2. Activity against some enzyme-producing bacteria. Certain bacteria make beta-lactamase enzymes that disable some beta-lactam antibiotics. Faropenem can work against some of these organisms, but results differ by bacterium and resistance mechanism. It is not a universal answer to resistant infections.\n\n3. Easy-to-prepare format. The tablet is dispersed in water following the pack instructions, which helps those who struggle with swallowing conventional tablets.\n\n4. Focused treatment. Matched to the right infection, it targets the responsible bacteria. Choosing the right antibiotic improves outcomes and limits needless antibiotic exposure.\n\n5. Oral route. When oral therapy is clinically suitable, treatment can proceed without injections. The prescriber decides the route based on the patient’s condition.\n\nHow Faropenem Works\n\nFaropenem attaches to penicillin-binding proteins, which bacteria rely on to assemble and maintain their cell walls. With these proteins blocked, the wall cannot form properly, the bacterial structure weakens and the cell dies. This makes Faropenem bactericidal against susceptible organisms. It does not act on viruses and cannot treat every bacterial infection.\n\nDosing and Administration\n\nThe dose is set by the doctor after considering age, body weight (where relevant), the type and seriousness of the infection, and kidney function.\n\nDose: use only the strength and quantity prescribed.\nFrequency: follow the daily schedule given to you; do not alter it yourself.\nDuration: finish the prescribed course without lengthening or shortening it unless your doctor says so.\nPreparation: disperse the tablet as directed in the leaflet or by your pharmacist.\nMissed dose: check the leaflet or ask a pharmacist. Never double up to make up for a forgotten dose.\n\nNo single dosing plan fits all patients, so a general range should never replace a personal prescription.\n\nPossible Side Effects\n\nAs with other antibiotics, reactions can occur, and they vary from person to person.\n\nMilder effects may include:\n\nNausea or stomach upset\nAbdominal discomfort\nLoose stools or diarrhoea\nRash or itching\nHeadache or dizziness\n\nSpeak to a healthcare professional if these continue, become bothersome or get worse.\n\nGet medical help promptly for:\n\nSerious allergy: swelling of the face, lips, tongue or throat, or trouble breathing is an emergency.\nSevere diarrhoea: persistent, watery or bloody stools may signal a serious antibiotic-related complication.\nSevere skin reaction: widespread rash, blisters or peeling skin needs urgent assessment.\nLiver concerns: yellow skin or eyes, or dark urine, should be checked quickly.\n\nThis list is not exhaustive. Refer to the product information and your doctor for advice specific to you.\n\nPrecautions and Warnings\nAllergies: tell your doctor about any past allergy to Faropenem, penicillins, cephalosporins or other beta-lactams.\nKidney health: report any kidney disease or reduced function, as it can affect suitability and dosing.\nPregnancy and breastfeeding: consult your doctor first if you are pregnant, planning pregnancy or nursing. Use only after a personal benefit–risk assessment.\nOther medicines: share a full list of prescription drugs, over-the-counter products and supplements so interactions can be checked.\nAntibiotic resistance: take Faropenem only for a suitable bacterial infection. Misuse and incorrect dosing fuel resistance.\nMedical history: discuss existing conditions and earlier drug reactions before starting.\nWho Is It For?\n\nFaropinom 100 DT may be considered for patients who need an antibiotic for a susceptible bacterial infection and for whom this dispersible form is suitable. The prescriber decides based on examination, the likely or confirmed organism, individual risk factors and current guidance. It should not be self-started for fever, cough or sore throat without first establishing that an antibiotic is needed.\n\nBuying Faropinom 100 DT in India\n\nBefore purchasing, confirm the brand, strength, manufacturer and the legitimacy of the seller. For safety:\n\nGet a prescription from a registered medical practitioner.\nBuy from a licensed pharmacy or a duly authorised online pharmacy.\nInspect the name, strength, batch number, expiry date and pack condition.\nStore it as the packaging directs.\nAsk the pharmacist if anything is unclear.\n\nPrice and availability: these differ by manufacturer, pack size, pharmacy and location. Confirm current details with a licensed seller rather than an unverified figure.\n\nFrequently Asked Questions\n\n1. What is Faropinom 100 DT prescribed for?\nIt contains Faropenem 100 mg and is used for certain bacterial infections when the organism is susceptible and the medicine is clinically suitable.\n\n2. Is it an antibiotic?\nYes. Faropenem is a penem-class beta-lactam that disrupts bacterial cell-wall formation.\n\n3. What is the active ingredient?\nFaropenem 100 mg. Check the pack for full composition details.\n\n4. Will it cure a common cold?\nNo. Colds are viral, and antibiotics do not act on viruses.\n\n5. How do I take it?\nExactly as prescribed. Prepare the dispersible tablet in water as described in the leaflet or by your pharmacist.\n\n6. What is the right dose?\nIt depends on the infection, your age, kidney function and other individual factors. Follow your doctor’s prescription.\n\n7. How long is the course?\nThe duration depends on the infection and your response. Complete the course unless your doctor changes it.\n\n8. What side effects can occur?\nStomach upset, nausea, diarrhoea, headache and skin reactions are possible. Seek advice if they persist or become severe.\n\n9. Can it cause diarrhoea?\nYes, as antibiotics can. Contact a healthcare professional quickly if it is severe, long-lasting or bloody.\n\n10. Can I stop once I feel better?\nDo not stop or alter treatment on your own. Talk to your doctor about side effects or if you think treatment is no longer needed.\n\n11. Is it safe in pregnancy?\nA doctor must assess this individually. Do not use it in pregnancy without medical advice.\n\n12. Can I use it while breastfeeding?\nAsk your doctor first. The decision rests on available safety data and your circumstances.\n\n13. Can people with kidney problems take it?\nThey should tell their doctor beforehand, who will decide on suitability and any adjustment.\n\n14. Is Faropenem a penicillin?\nNo, it is a penem. Both are beta-lactams, so discuss any antibiotic allergy history with your prescriber.\n\n15. Is alcohol allowed during treatment?\nAsk your doctor or pharmacist, especially if you have other conditions or take other medicines. Avoid alcohol if it worsens symptoms.\n\n16. What if I miss a dose?\nConsult the leaflet or your pharmacist. Do not take a double dose unless a professional tells you to.\n\n17. Does it work on resistant bacteria?\nIt may act on certain bacteria that resist some other antibiotics, but this depends on the organism and resistance mechanism. Medical assessment is essential.\n\n18. Can it be used for any infection?\nNo. It is for suitable bacterial infections only, chosen through clinical assessment and, where needed, lab testing.\n\n19. What does it cost in India?\nConfirm the current price with a licensed pharmacy, as it varies by pack size, maker and location.\n\n20. Where can I buy it?\nEnquire at a licensed local or authorised online pharmacy. A valid prescription may be required under applicable rules.\n\nConclusion\n\nFaropinom 100 DT is a dispersible Faropenem 100 mg antibiotic for selected bacterial infections, to be used under a qualified healthcare professional’s guidance. It works by disrupting bacterial cell-wall formation, and the dispersible form offers an alternative for patients who find standard tablets difficult.\n\nResponsible use depends on accurate diagnosis, the right antibiotic choice, sticking to the prescribed regimen and watching for side effects. Always consult a healthcare professional before starting, stopping or changing antibiotic treatment.", "price": 590.0, "discountamount": 177.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2506, "imageuri": "https://productimages.withfloats.com/actual/6ae2fef754689b1ff0217bf5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ae2fef754689b1ff0217bf5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-29T08:08:20.798Z", "updatedon": "2026-10-29T08:08:20.798Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//faropenem-disperible-tablets-100-mg/2506", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Faropinom 100 DT", "category": null, "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad74702e53c888beeab308d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets", "description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n", "price": 210.0, "discountamount": 147.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2505, "imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:48:34.116Z", "updatedon": "2026-10-20T10:48:34.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 10", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad7442bf24c5a4bbccf4b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets", "description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.", "price": 230.0, "discountamount": 69.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2504, "imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:36:27.325Z", "updatedon": "2026-10-20T10:36:27.325Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 25", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }